Item 9.01. Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired
Zikani's audited financial statements as of and for the years ended
(b) Pro Forma Financial Information
The unaudited pro forma condensed consolidated financial statements of the
Company as of and for the three months ended
(c) Exhibits: Exhibit No. Description 23.1 Consent ofMoody, Famiglietti & Andronico, LLP , Independent Registered Public Accounting Firm 99.1Zikani Therapeutics, Inc. audited financial statements as of and for the years endedDecember 31, 2020 and 2019 99.2Zikani Therapeutics, Inc. unaudited condensed financial statements as of and for the three months endedMarch 31, 2021 99.3 Unaudited pro forma condensed consolidated financial statements ofEloxx Pharmaceuticals, Inc. 104 Inline XBRL for the cover page of this Current Report on Form 8-K
© Edgar Online, source